Animal Rights Kills Ebola Research – Shell

Animal Rights Kills Ebola Research – Shell

Justin Gills, Washington Post Staff Writer. “Scientists Achieve Unexpected Success with Ebola Vaccine”. 2003 http://www.ph.ucla.edu/epi/bioter/unexpsucebolavac.html

"In terms of what we need for countermeasures against terrorism, it's highly significant," said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which sponsored much of the research. "This could be a real advance in our ability to contain Ebola."

At the same time, the work, to be reported in tomorrow's edition of the journal Nature, raises complex new scientific questions with implications for national security.

The new technique used to create the Ebola vaccine, which involved sophisticated genetic engineering, may be used to create vaccines against other germs, including AIDS and potential terrorist agents. But studies suggest it's possible that any given person could receive a vaccine of this type only once -- subsequent shots might fail to work. That means the government must think carefully about how to use the approach, and about whether to try to maximize its value by, for instance, creating a combination vaccine that would protect against multiple bioterror agents.
B)LINK – ANIMAL RIGHTS WOULD REQUIRE THE RELEASE OF ALL ANIMALS FROM RESEARCH

Barbara Noske, Researcher, Department of Social Philosophy, University of Amsterdam, 1994, The Great Ape Project: equality beyond humanity, eds. Cavalieri & Singer, p. 265

Moreover, declaring humans and other great apes to be all of one kind—as belonging to a community of equal subjects—cannot but lead to a total revision of current ape research procedures. The proposed change of attitude calls for a release of all ape objects of study from human laboratories. Instead it seems fitting that humans should ask permission from their ape subjects before intruding upon their societies, just as anthropologists need to do whenever they come upon a foreign community of people. Incidentally, both Fossey and Goodall have made it quite clear that in their respective research situations they initially felt like intruding visitors.
C)IMPACTS –

FUTURE EBOLA ATTACKS WILL CAUSE EXTINCTION

The Toronto Sun, October 16, 1994, Pg. M6
Nor did the media go beyond Surat and explain how this largely inconsequential epidemic, a kind of false alarm in a much larger microbial saga, was another sharp warning of our species' growing vulnerability to infectious disease. Imagine, for a moment, if Surat had aroused a different airborne microbe, a so-called "emerging virus," beyond the waning reach of antibiotics. Suppose that the headliner germ had been a new strain of Ebola that dissolves internal organs into a bloody tar or the mysterious "X" virus that killed thousands in the Sudan last year. Had such a microbe been unleashed, the final death toll might have been millions, and the world might now be mourning a "new Black Death." The planet, in fact, might be an entirely different and emptier place altogether.

Ebola Research DA – Links – Apes Key

Justin Gills, Washington Post Staff Writer. “Scientists Achieve Unexpected Success with Ebola Vaccine”. 2003 http://www.ph.ucla.edu/epi/bioter/unexpsucebolavac.html

The Vaccine Research Center, a unit of Fauci's institute at the National Institutes of Health, in Bethesda, proved three years ago that Ebola vaccination would be possible. But the initial approach was complicated and time-consuming, involving two different types of shots and taking six months or longer to produce immunity. Such a vaccine might be useful to protect health-care workers or soldiers -- it remains under development, in fact -- but it would not be useful to stop an Ebola epidemic.

As NIH worked on a vaccine, the lab in Frederick that works with live Ebola virus, part of the U.S. Army Medical Research Institute of Infectious Diseases, met repeated frustration in its own attempts at vaccine development, creating vaccines that worked in rodents but failed in monkeys, whose biology closely resembles that of humans. At the same time, the Army lab was perfecting an "animal model" the closely resembles human Ebola disease, using macaques, a type of monkey.

Charles Siebert, Freelance Writer and Director, July 24, 2005, New York Times Magazine, p. 61

For some, however, the chimp remains an indispensable tool for medical research, and scientists have expressed fears that by endorsing the retirement of even a select number of chimps, the government might be opening the door to their removal from research altogether. Stuart Zola, director of the Yerkes National Primate Center, fully supports animal sanctuaries but argues that there will always be a need to study chimpanzees. “The only thing we can predict with certainty is that there are going to be new epidemics that will arise, as they have throughout history, and the chimp is going to be a unique animal model.”